Zukanorm M 1000mg/100mg Tablet SR

The sustained-release (SR) formulation ensures prolonged therapeutic plasma concentrations, improving glycemic control while minimizing gastrointestinal side effects commonly associated with Metformin. Zukanorm M is prescribed as an adjunct to diet and exercise to improve glycemic parameters in patients inadequately controlled on monotherapy or lifestyle modifications alone. It is essential to monitor renal function prior to and during treatment, as Metformin is contraindicated in patients with significant renal impairment.

Common adverse effects include mild gastrointestinal disturbances and, rarely, hypoglycemia when used in combination with other antidiabetic agents. This combination therapy offers a complementary mechanism of action targeting multiple pathophysiological defects in type 2 diabetes, thereby optimizing glycemic control and reducing the risk of diabetes-related complications.